darunavir has been researched along with danoprevir in 3 studies
Studies (darunavir) | Trials (darunavir) | Recent Studies (post-2010) (darunavir) | Studies (danoprevir) | Trials (danoprevir) | Recent Studies (post-2010) (danoprevir) |
---|---|---|---|---|---|
1,148 | 224 | 780 | 18 | 0 | 11 |
1,148 | 224 | 780 | 62 | 30 | 56 |
Protein | Taxonomy | darunavir (IC50) | danoprevir (IC50) |
---|---|---|---|
Genome polyprotein | 0.0002 | ||
Non-structural protein 4A | 0.0002 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Marsault, E; Peterson, ML | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Talluri, S | 1 |
1 review(s) available for darunavir and danoprevir
Article | Year |
---|---|
Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery.
Topics: Amino Acid Sequence; Animals; Cyclization; Drug Discovery; Enzyme Inhibitors; Humans; Macrocyclic Compounds; Protein Binding; Receptors, G-Protein-Coupled | 2011 |
2 other study(ies) available for darunavir and danoprevir
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Molecular Docking and Virtual Screening Based Prediction of Drugs for COVID-19.
Topics: Antiviral Agents; Benzazepines; COVID-19; COVID-19 Drug Treatment; Cyclopropanes; Darunavir; Drug Evaluation, Preclinical; Drug Repositioning; High-Throughput Screening Assays; Humans; Indoles; Isoindoles; Lactams, Macrocyclic; Molecular Docking Simulation; Proline; Saquinavir; SARS-CoV-2; Sulfonamides | 2021 |